stockrow
Saturday 7 November 2026
Export DWTX’s income statement to Excel — free account
Dogwood Therapeutics, Inc
DWTX Healthcare Biotechnology
- EPS
- +82.9%
- Free cash flow
- +10.3%
Quarter to June 2026, against a year earlier
1.32
0.28
+26.92%
Follow DWTX
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
248.89% | (109.66%) | (90.31%) | (143.45%) | |
| (84.81%) | (38.50%) | (29.47%) | (40.68%) | ||
ROIC |
(29.46%) | (25.57%) | (26.54%) | (41.22%) | |
Return on Tangible Assets |
(440.56%) | (659.52%) | (227.34%) | (439.16%) | |
Free Cash Flow per Share |
(9.44) | (3.14) | (0.46) | (0.44) | |
Free Cash Flow |
(18.11) | (15.62) | (15.52) | (15.11) | |
| Other line items | |||||
Cash ROIC |
(20.70%) | (19.18%) | (16.54%) | (19.38%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.01 | 0.01 | 0.00 | (0.06) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.45 | 0.44 | 0.55 | 0.42 | |
Depreciation/Fixed assets |
8.17 | 4.25 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(9.44) | (3.14) | (0.46) | (0.44) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates